Explore how dual targeting of HDAC6 and Hsp90 proteins creates a powerful approach to combat treatment-resistant cancers through synergistic mechanisms.
Explore the latest advances in non-hydroxamate HDAC6 inhibitors, their medicinal chemistry, and therapeutic potential for cancer and neurodegenerative diseases.